Correction of current report 7/2020 regarding commencement of public offering with the exclusion of the pre-emptive right of the Company’s current shareholders in the private subscription of series G ordinary bearer shares and conclusion of the placement agreement
Current report No. 9/2020
Date: 20.01.2020 r.
Legal basis: Article 17(1) of MAR – inside information
Management Board of Medicalgorithmics S.A. (The “Company”) hereby publishes the correction of current report No. 9/2020 regarding commencement of public offering with the execution of the pre-emptive right to the Company’s current shareholders in the private subscription of series G ordinary bearer shares and conclusion of the placement agreement.
The correction regards the content of the attachment to the report entitled “information about the account balance on the day of priority”.
In the abovementioned attachment to the current report 7/2020 was erroneously indicated the priority date as December 22, 2020, instead of December 22, 2019, and was mistakenly indicated in the footer of the document (attachment) the resolution number of the Extraordinary General Meeting as 3/1/2010 instead of number 3/1/2020.
Relevant wording of the annex to the report before correction read as follows:
1) as at the end of Priority Day*, i.e. on December 22, 2020, on the securities account conducts by us, he/she had (…);
2) *in accordance with Resolution No. 3/1/2010 of January 7, 2020, of the Extraordinary General Meeting of Medicalgorithmics S.A. with its registered office in Warsaw in the matter of (i) increasing the Company’s share capital by issuing new series G ordinary bearer shares and depriving existing shareholders of all pre-emptive rights to all new series G shares, (ii) dematerialisation and applying for admission and introduction of new issue shares G series and rights to G series shares for trading on the regulated market operated by the Warsaw Stock Exchange S.A. and (iii) amendments to the Company’s Articles of Association.
After correction, the relevant wording, as set out in points 1 and 2 above, reads as follows:
1) as at the end of Priority Day*, i.e. on December 22, 2019, on the securities account conducts by us, he/she had (…);
2) *in accordance with Resolution No. 3/1/2020 of January 7, 2020, of the Extraordinary General Meeting of Medicalgorithmics S.A. with its registered office in Warsaw in the matter of (i) increasing the Company’s share capital by issuing new series G ordinary bearer shares and depraving existing shareholders of all pre-emptive rights to all new series G shares, (ii) dematerialisation and applying for admission and introduction of new issue shares G series and rights to G series shares for trading on the regulated market operated by the Warsaw Stock Exchange and (iii) amendments to the Company’s Articles of Association.
In the attachment, the Company encloses the corrected attachment to the report 7/2020 taking into consideration the abovementioned corrections.